Certain fascin binding compounds for spinogenesis
AssigneeSpinogenix, Inc.
InventorsStella T. Sarraf, Vincent F. Simmon, Peter W. Vanderklish
Life of this patent
Estimating the term…
Abstract
In some embodiments, a method of promoting spinogenesis in a patient is provided, comprising administering to a patient in need thereof a therapeutically effective amount of imipramine, semapimod, or brilacidin, or a pharmaceutically acceptable salt of each thereof.
Claims12
A method of promoting spinogenesis in a neuron, comprising contacting the neuron with imipramine, or a pharmaceutically acceptable salt thereof.
A method of treating or preventing a neuronal disease or disorder comprising administering to a patient in need thereof a therapeutically effective amount of imipramine, or a pharmaceutically acceptable salt thereof, provided that the neuronal disease or disorder is not a mood disorder.
A method of promoting spinogenesis in a neuron, comprising contacting the neuron with semapimod or a pharmaceutically acceptable salt thereof.
A method of promoting spinogenesis in a neuron, comprising contacting the neuron with brilacidin or a pharmaceutically acceptable salt thereof.
A method of treating or preventing a neuronal disease or disorder comprising administering to a patient in need thereof a therapeutically effective amount of semapimod, or a pharmaceutically acceptable salt thereof.
A method of treating or preventing a neuronal disease or disorder comprising administering to a patient in need thereof a therapeutically effective amount of brilacidin, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.